###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 5 6 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 9 11 9 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 5 11 5 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
GpnmbR150X allele must be present in bone marrow derived cells to mediate DBA/2J glaucoma
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
The Gpnmb gene encodes a transmembrane protein whose function(s) remain largely unknown. Here, we assess if a mutant allele of Gpnmb confers susceptibility to glaucoma by altering immune functions. DBA/2J mice have a mutant Gpnmb gene and they develop a form of glaucoma preceded by a pigment dispersing iris disease and abnormalities of the immunosuppressive ocular microenvironment.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 654 660 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 692 698 689 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
We find that the Gpnmb genotype of bone-marrow derived cell lineages significantly influences the iris disease and the elevation of intraocular pressure. GPNMB localizes to multiple cell types, including pigment producing cells, bone marrow derived F4/80 positive antigen-presenting cells (APCs) of the iris and dendritic cells. We show that APCs of DBA/2J mice fail to induce antigen induced immune deviation (a form of tolerance) when treated with TGFbeta2. This demonstrates that some of the immune abnormalities previously identified in DBA/2J mice result from intrinsic defects in APCs. However, the tested APC defects are not dependent on a mutant Gpnmb gene. Finally, we show that the Gpnmb mediated iris disease does not require elevated IL18 or mature B or T lymphocytes.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
These results establish a role for Gpnmb in bone marrow derived lineages. They suggest that affects of Gpnmb on innate immunity influence susceptibility to glaucoma in DBA/2J mice.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 572 573 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1136 1138 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 116 122 <span type="species:ncbi:9606">people</span>
###xml 920 925 <span type="species:ncbi:10090">mouse</span>
###xml 959 964 <span type="species:ncbi:10090">mouse</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
The glaucomas are a common group of potentially blinding diseases that by 2010 will affect approximately 60 million people worldwide [1]. The glaucomas share a clinical phenotype including a progressive degeneration of the optic nerve [2,3]. This glaucomatous optic neuropathy causes a progressive and irreversible loss of vision, and may lead to complete blindness. Significant known risk factors for glaucoma include elevated intraocular pressure (IOP), aging, positive family history, race, abnormal optic nerve head morphology and decreased central corneal thickness [4-12]. Of these, the only currently modifiable risk factor is IOP, which is the target of all existing glaucoma treatments [13-15]. One means of gaining a better understanding of glaucoma pathogenesis, and ultimately the creation of new therapeutic interventions, is to study the underlying molecular pathways with experimental systems such as the mouse. With the recent descriptions of mouse strains and techniques relevant to studying glaucoma, genetic approaches in mice offer great promise for testing new and potentially novel hypotheses related to glaucoma [16-19].
###end p 9
###begin p 10
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
###xml 1179 1183 <span type="species:ncbi:10090">mice</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
Experiments with DBA/2J (D2) mice have suggested that immune abnormalities may contribute to some forms of glaucoma [20,21]. D2 mice develop a form of glaucoma involving a pigment dispersing iris disease that aberrantly deposits pigment throughout the anterior chamber, including the drainage structures of the eye [22-24]. As a consequence, D2 and several closely related strains develop elevated IOP and glaucomatous neuropathy [24-30]. Eyes of D2 mice also exhibit multiple abnormalities in ocular immune privilege [20], including deficient anterior chamber associated immune deviation (ACAID). Importantly, the iris pigment dispersion component of the D2 iris disease and the inability to support ACAID are simultaneously rescued when their marrow is repopulated with cells from B6D2F1 mice [20]. While the bone marrow origin of immune cells involved in ACAID explains the restoration of ACAID by B6D2F1 bone marrow cells (BMC), the simultaneous resolution of the pigment dispersing iris disease links this disease to bone marrow derived cells. The B6D2F1 mice that served as a source of normal BMC are offspring of a cross between glaucoma prone D2 and normal C57BL/6J (B6) mice. These B6D2F1 mice are heterozygous for all B6 and D2 specific alleles across the entirety of the autosomal genome. Therefore, no specific genes were mechanistically implicated in the recovery of ACAID or the iris disease. The goal of the current experiments is to identify the gene(s) responsible for mediating this BMC contribution to D2 phenotype.
###end p 10
###begin p 11
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 543 549 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 728 734 728 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1133 1139 1133 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 1228 1232 <span type="species:ncbi:10090">mice</span>
Genetic experiments have previously shown that mutations in two genes digenically promote glaucoma in D2 mice, Tyrp1 and Gpnmb [22,23]. The Tyrp1 gene encodes a relatively well characterized melanosomal enzyme that is required for eumelanogenesis and is localized at the melanosomal membrane. So far there are no reports of either expression or influence of this gene on cell types derived from the bone marrow. Therefore, Tyrp1 is unlikely to be relevant in the BMC mediated glaucoma phenotype of D2 mice. Less is known concerning Gpnmb. The Gpnmb gene is predicted to encode a transmembrane protein with homology to the melanosomal protein, silver (pMel17), but the function(s) of GPNMB remain largely unknown. Interestingly, Gpnmb is expressed by some BM derived cell types [31]. Recent studies demonstrate that GPNMB is expressed by macrophages and functions as a negative regulator of macrophage mediated inflammatory responses [32]. In another study, it was reported that GPNMB binds activated T cells. This binding causes inhibition of TCR-induced T-cell activation for both primary and secondary immune responses [33]. Thus, Gpnmb is an attractive candidate that potentially influences the BMC mediated phenotypes in D2 mice.
###end p 11
###begin p 12
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 222 228 222 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
Here, we test the hypothesis that the Gpnmb gene contributes to the bone marrow dependent events in D2 glaucoma. Using D2 mice that only differ in Gpnmb genotype [34], we demonstrate that BMC lineages containing wild-type Gpnmb can rescue both the pigment dispersing iris disease and IOP elevation of D2 mice. Because GPNMB protein localizes to BM derived antigen-presenting cells (APCs) of the iris and to cultured dendritic cells, we assessed potential phenotypes that may be modulated by these APCs. First, we find that APCs of D2 mice are abnormal in that they fail to induce ACAID, this effect is not dependent on Gpnmb. Second, we examined aqueous humor levels of IL18. Bone marrow derived APCs in the iris are a potential source of IL18 [35] and IL18 is reported to become elevated in the aqueous humor of D2 mice as disease progresses [21]. In contrast to the previous report [21], we find no evidence for involvement of IL18 in the D2 disease. Surprisingly, we finally show that effectors of adaptive immune responses, mature B or T lymphocytes, are not necessary to mediate the glaucoma inducing iris disease of D2 mice.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
Gpnmb is a candidate for mediating BM derived contributions to D2 ocular disease
###end title 14
###begin p 15
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 359 365 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 368 374 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 750 756 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 805 811 805 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 921 922 921 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
We have previously shown that the D2 iris disease is strongly influenced by a BMC lineage [20]. Our consideration of candidates capable of mediating this influence was based in part on previous genetic experiments demonstrating that the D2 iris disease is initiated by the digenic interaction of the Tyrp1 and Gpnmb genes [22,23]. To ascertain whether either Tyrp1 or Gpnmb are plausible candidates for mediating the BMC contributions to D2 iris disease, semi-quantitative RT-PCR was performed to compare gene expression patterns of these genes in iris and bone marrow. Since valid candidates would likely be expressed in cells of the immune system, their expression levels in lymph nodes and thymus were also tested. Supporting a potential role for Gpnmb in bone marrow derived phenotypes, expression of Gpnmb was detected in all of these tissues. In contrast, the expression of Tyrp1 was limited to only the iris (Fig. 1).
###end p 15
###begin p 16
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Gpnmb </italic>is a candidate for mediating BM derived contributions to D2 glaucoma</bold>
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 367 368 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 403 405 403 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
Gpnmb is a candidate for mediating BM derived contributions to D2 glaucoma. A). As expected for a candidate capable of mediating the BM derived contributions to the D2 form of glaucoma, Gpnmb is expressed in BM derived cells. Agarose gel of designated RT-PCR products amplified from iris (I), bone marrow (BM), lymph node (L), or thymus (T) of normal C57BL/6J mice. (B) Iris lysates from D2 and D2-Gpnmb+ mice were analyzed on Western blot with anti-GPNMB antibody (B). There is no protein of the expected size for GPNMB (arrow) in the D2 lysate. The faint bands of lower molecular weight likely represent background cross-reactivity of the antibody.
###end p 16
###begin p 17
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 110 112 110 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 106 112 106 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 131 137 131 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 294 300 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 377 383 377 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 475 477 475 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 471 477 471 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rn18s</italic>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 599 601 599 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 595 601 595 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 644 650 644 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 851 857 851 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 939 945 939 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
Having found that Gpnmb was expressed in the appropriate tissues, we next assessed the nature of the GpnmbR150X mutation. The GpnmbR150X mutation in D2 mice creates a premature stop codon. As a result of nonsense-mediated mRNA decay, the mutation is predicted to result in a severe decrease in Gpnmb transcript levels [36]. To test this, a quantitative real-time PCR assay for Gpnmb was performed. Expression in irides of young predisease D2 mice homozygous for the GpnmbR150X mutation was compared to age and sex matched wild-type controls. With samples normalized to levels of Rn18s, the GpnmbR150X mutation resulted in a severe reduction in Gpnmb transcript levels (~18 fold, data not shown). In agreement with this, no protein with the expected molecular size was detected by Western analysis using a GPNMB antibody (Fig. 1B). Similar analysis of Tyrp1 levels demonstrated no significant change in transcript levels. The expression of Gpnmb in immune tissues and the absence of GPNMB protein in R150X mutants support the hypothesis that this mutation disrupts BMC lineage dependent functions of GPNMB and that it may be responsible for bone marrow mediated aspects of the D2 disease.
###end p 17
###begin title 18
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
A functional requirement for Gpnmb in bone marrow
###end title 18
###begin p 19
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 278 280 278 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 274 280 274 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 428 430 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A&#8211;J</xref>
###xml 584 590 584 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
To genetically test whether the GPNMB genotype of BM derived lineages influences the D2 iris disease, we took advantage of the DBA/2J substrain, D2-Gpnmb+ that has a wild-type Gpnmb allele but no other known differences to modern D2 mice [34]. Whereas D2 mice with the GpnmbR150X mutation develop an iris disease characterized by significant pigment dispersion, iris atrophy, and anterior chamber enlargement, irides of D2-Gpnmb+ mice exhibit far milder phenotypes (Fig. 2A-J). Using these mice as donors and recipients in bone marrow transfers, we next asked whether the genotype of Gpnmb in BMC lineages was capable of influencing iris phenotypes.
###end p 19
###begin p 20
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D2-<italic>Gpnmb</italic><sup>+ </sup>bone marrow suppresses iris depigmentation and anterior chamber enlargement</bold>
###xml 678 684 678 684 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A to E</bold>
###xml 703 708 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 708 710 708 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 790 795 790 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 795 797 795 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 795 797 795 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 906 911 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 911 913 911 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1061 1067 1061 1067 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F to J</bold>
###xml 1111 1116 1111 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1116 1117 1116 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1120 1122 1120 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1116 1122 1116 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 1692 1698 1692 1698 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K to O</bold>
###xml 1703 1708 1703 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1708 1709 1708 1709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1734 1739 1734 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1739 1740 1739 1740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1743 1745 1743 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1739 1745 1739 1745 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 2066 2072 2064 2070 <bold xmlns:xlink="http://www.w3.org/1999/xlink">P to T</bold>
###xml 2102 2107 2100 2105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 2107 2109 2105 2107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2207 2212 2203 2208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 2212 2214 2208 2210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 716 718 <span type="species:ncbi:10090">WT</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
###xml 1757 1759 <span type="species:ncbi:10090">WT</span>
###xml 2131 2133 <span type="species:ncbi:10090">WT</span>
###xml 2214 2218 <span type="species:ncbi:10090">mice</span>
D2-Gpnmb+ bone marrow suppresses iris depigmentation and anterior chamber enlargement. Representative eyes of the indicated strains and ages are shown. The three left most columns show broad beam illumination to assay for the presence of dispersed pigment within the anterior chamber and iris stromal morphology. The fourth column shows a transilluminating view assaying the degree of iris depigmentation, detectable as red areas within the image where reflected light is passing through the iris. The fifth column show anterior chamber dimensions. Each row represents a different genetic context of either unmanipulated mice (rows 1 & 2) or bone marrow chimeras (rows 3 & 4). (A to E) Unmanipulated D2-Gpnmb+ mice (WT) exhibit a characteristic iris stromal atrophy phenotype caused by the Tyrp1b mutation that is largely devoid of significant pigment dispersion at all examined ages (1-15 mo). Eyes of D2-Gpnmb+ mice do not develop significant transillumination and maintain a normal anterior chamber depth with very little space between the iris and cornea. (F to J) Unmanipulated D2 mice (homozygous for the GpnmbR150X mutation) develop a severe pigment dispersing iris disease. At 5-6 mos, the initial stages of iris disease are apparent by a slight peripupillary thickening and subtle changes to the morphology of the iris stroma (note slightly roughened appearance). Subsequently, dispersed pigment becomes aberrantly deposited on a variety of structures including the surface of the iris, lens, and cornea. Dispersed pigment is also deposited in the aqueous humor drainage structures, leading to increased IOP and enlargement of the anterior chamber (space indicated by arrows in J). (K to O) D2-Gpnmb+marrow transferred to D2.GpnmbR150X recipients (WT --> R150X) exhibit a pronounced suppression of the typical D2 disease progression. Most notably, the extent of iris degeneration is lessened (compare the peripupillary region of M vs H, and degree of transillumination defects in N vs I) and the anterior chamber does not become enlarged (compare O vs J). (P to T) D2 marrow transferred to D2-Gpnmb+ recipients (R150X --> WT) exhibit no alterations in ocular phenotype compared to unmanipulated D2-Gpnmb+ mice.
###end p 20
###begin p 21
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K&#8211;O</xref>
###xml 307 312 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 312 314 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 497 502 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 502 504 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 757 761 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K&#8211;O</xref>
###xml 767 771 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F&#8211;J</xref>
###xml 846 851 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 851 852 849 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 855 857 853 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 851 857 849 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 867 869 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 870 872 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 937 942 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 942 944 940 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1018 1022 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2P&#8211;T</xref>
###xml 1047 1052 1043 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1052 1054 1048 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1180 1185 1176 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1185 1187 1181 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1206 1210 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2P&#8211;T</xref>
###xml 1216 1220 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A&#8211;E</xref>
###xml 1263 1268 1259 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1268 1269 1264 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1272 1273 1268 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 1268 1273 1264 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 1379 1384 1375 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1384 1385 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1388 1390 1384 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1384 1390 1380 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 285 287 <span type="species:ncbi:10090">WT</span>
###xml 315 317 <span type="species:ncbi:10090">WT</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 989 991 <span type="species:ncbi:10090">WT</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1511 1515 <span type="species:ncbi:10090">mice</span>
Lethally irradiated D2 mice were reconstituted with D2-Gpnmb+bone marrow and followed clinically for indications of iris disease (Fig. 2K-O). In all figures and text, the genotype of donor bone marrow is written first followed by an arrow and then the recipient genotype. For example, WT --> R150X where D2-Gpnmb+ (WT) bone marrow was transferred into D2 mice homozygous for the R150X mutation. At ages when the D2 iris disease is normally severe, iris phenotypes in D2 mice reconstituted with D2-Gpnmb+ bone marrow were significantly rescued toward the wild-type iris phenotype. They developed less pigment dispersion, less transillumination, and less change in the dimensions of the anterior chamber as compared to both unmanipulated D2 mice (compare Fig 2K-O with 2F-J) and D2 mice that were reconstituted with standard D2 marrow that had the GpnmbR150X mutation [20,37]. The converse experiment reconstituting lethally irradiated D2-Gpnmb+ mice with standard D2 bone marrow (R150X --> WT) was also performed (Fig. 2P-T). Iris phenotypes of D2-Gpnmb+ mice reconstituted with standard D2 bone marrow were unaltered and maintained an iris indistinguishable from unmanipulated D2-Gpnmb+ mice (compare Fig. 2P-T with 2A-E). In sum, these results indicate that the GpnmbR150Xmutation results in the bone-marrow derived portion of the D2 iris disease. However, the influence of the GpnmbR150X mutation acting via bone marrow derived lineages is not itself sufficient toinduce the iris disease in otherwise healthy mice.
###end p 21
###begin title 22
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
IOP elevation in D2 mice can be modulated by Gpnmb bone marrow genotype
###end title 22
###begin p 23
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 199 201 199 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 507 509 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 582 586 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
In unmanipulated D2 mice, the depigmenting iris disease is typically followed by IOP elevation and enlargement of the anterior chamber. Because the iris disease of D2 mice reconstituted with D2-Gpnmb+ bone marrow is ameliorated, and the anterior chamber does not become enlarged, it is likely that these mice do not develop IOP elevation. To directly test this, IOP was measured at multiple ages for bone marrow chimera cohorts and unmanipulated D2 mice of differing Gpnmb genotypes (Fig. 3). 10-mo D2-Gpnmb+ mice had a relatively normal mean IOP of 16 mmHg, 10-mo unmanipulated D2 mice had an elevated mean IOP of 20 mmHg, and 10-mo D2 mice reconstituted with D2 marrow (R150X --> R150X - a syngeneic control for possible influence of bone marrow transfer itself) also had an elevated IOP of 20 mmHg.
###end p 23
###begin p 24
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Bone marrow genotype affects glaucomatous IOP elevation</bold>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 276 278 276 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 272 278 272 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 430 435 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 435 437 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 604 609 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 609 611 605 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 639 644 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 644 646 640 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 711 716 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 716 717 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 720 722 716 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 716 722 712 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 784 786 780 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 485 487 <span type="species:ncbi:10090">WT</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
Bone marrow genotype affects glaucomatous IOP elevation. Plot of IOP vs Gpnmb genotype, with age and numbers of mice indicated. D2-Gpnmb+ mice exhibit an average IOP typical of many non-glaucomatous mouse strains. As previously described, D2 mice (homozygous for the GpnmbR150X mutation) exhibit an elevated IOP at 10 mo of age, as do D2 mice receiving syngeneic bone marrow transfers (R150X --> R150X). Chimeric mice in which D2-Gpnmb+ bone marrow has been transferred into D2 hosts (WT --> R150X) continue to maintain non-glaucomatous IOP values, whether examined at 10 mo, or beyond. The IOPs of both Gpnmb+ mice and chimeric mice with Gpnmb+ bone marrow were significantly lower than those of all mice with GpnmbR150X mutant marrow (P < 0.002 for all comparisons at various ages, t test).
###end p 24
###begin p 25
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 143 149 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 268 273 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 273 275 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 407 412 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 412 413 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 416 418 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 412 418 408 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 69 71 <span type="species:ncbi:10090">WT</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 288 290 <span type="species:ncbi:10090">WT</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
Importantly, 10-mo D2 mice reconstituted with D2-Gpnmb+ bone marrow (WT --> R150X) had a mean IOP of 16 mmHg, indicating that the influence of Gpnmb in bone marrow was able to prevent IOP elevation from occurring. Furthermore, the IOP of D2 mice reconstituted with D2-Gpnmb+ bone marrow (WT --> R150X) remained at these normal levels to at least 16-mo. These results further support the conclusion that the GpnmbR150X mutation influences the glaucoma phenotype of D2 mice via BMC lineages.
###end p 25
###begin title 26
GPNMB localization within F4/80 positive APCs
###end title 26
###begin p 27
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 532 538 532 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 903 904 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 983 988 983 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E, F</xref>
###xml 1301 1307 1301 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1317 1319 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 627 632 <span type="species:ncbi:10090">mouse</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
Relatively little is known concerning the Gpnmb gene, or it's orthologs in other species [38-40]. Although the ocular localization of GPNMB protein has not previously been described, experiments have suggested two ocular cell types in which GPNMB would likely be found. First, GPNMB is likely to be present in melanin producing cells [22,41,42]. Second, GPNMB is likely to be present in BM derived APCs, including macrophages and a subset of dendritic cells (DCs) [31,32]. In order to begin identifying specific cell types in which Gpnmb may function, an anti-GPNMB antibody was used to localize GPNMB in normal adult C57BL/6J mouse eyes (Fig. 4). In adult C57BL/6J mice, we found that GPNMB is robustly detectable within multiple pigmented cells of the eye, including: melanocytes of the iris stroma and pigmented cells of the iris pigment epithelium, the pigmented epithelia of the ciliary body (Fig. 4 A-D), the choroid and to a lesser extent the retinal pigment epithelium (Fig. 4E, F). Diffuse low level labeling was observed throughout the neural retina. GPNMB was not detected in other ocular tissues such as the cornea or lens. In each of the pigmented tissues, GPNMB localization was punctate, likely as a consequence of localization within melanosomes. Though important for other aspects of Gpnmb function [43], there is no evidence that any of the pigment producing cells of the eye are derived from the bone marrow. Thus, we next examined whether GPNMB is present in ocular APCs.
###end p 27
###begin p 28
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GPNMB localizes to multiple pigmented tissues of the eye and ocular APCs</bold>
###xml 306 313 306 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A, B) </bold>
###xml 352 359 352 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C, D) </bold>
###xml 413 420 413 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E, F) </bold>
###xml 429 433 429 433 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) </bold>
###xml 650 654 650 654 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H) </bold>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 693 695 693 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 772 776 772 776 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I, J</bold>
###xml 880 884 880 884 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I) </bold>
###xml 918 923 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 923 924 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 927 928 927 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 923 928 923 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 1035 1039 1035 1039 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(J) </bold>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
GPNMB localizes to multiple pigmented tissues of the eye and ocular APCs. Cryosections of whole eyes from wild-type C57BL/6J mice were imaged in brightfield or phase illumination. GPNMB protein localization was imaged by fluorescent immunohistochemistry and confocal microscopy (red). GPNMB is present in: (A, B) multiple pigmented tissues of the eye, (C, D) iris and pigmented epithelia of the ciliary body, and (E, F) choroid. (G) Iris of normal C57BL/6J mouse showing GPNMB (red) within cells labeled by F4/80 (green). An 8 micron Z-series composite demonstrating F4/80 labeling the border of a single cell (dashed white circle) containing GPNMB. (H) BM derived dendritic cell from D2-Gpnmb+ marrow differentiated in cell culture showing punctate expression of GPNMB, (I, J) Negative controls were labelled and imaged with identical conditions and exhibited negligible signal. (I) Eyes from D2 mice (homozygous for GpnmbR150X) have no signal for GPNMB, an inset on right hand corner shows the brightfield image of the same section. (J) BM derived dendritic cells from D2 mice have no staining for GPNMB. Scale bars A-F, I = 500 mum, G, H, J = 10 mum.
###end p 28
###begin p 29
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
The iris normally contains a robust population of APCs [44] and GPNMB has previously been demonstrated to be present in mouse DCs [31]. To determine if a portion of GPNMB in the iris is within APCs, the APC marker F4/80 was tested for co-localization with GPNMB protein. In adult C57BL/6J mice, GPNMB was indeed present within the cytoplasm of iridial F4/80 positive cells (Fig. 4G). To assess the localization of GPNMB in DC lineages, bone marrow progenitors were grown in cell culture, stimulated to differentiate into DCs, and utilized for immunohistochemistry. In DC cells grown in these conditions, GPNMB was observed in intracellular granules (Fig. 4H). Because F4/80 positive APCs and DCs are BM derived cell lineages, this result indicates that the bone marrow functions of Gpnmb are likely to be mediated, in part or in whole, by these cells.
###end p 29
###begin title 30
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
Gpnmb deficient APCs fail to induce immune deviation
###end title 30
###begin p 31
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
We next determined the effect of the Gpnmb mutation on the ability of APCs to induce immune deviation. The healthy eye exists in a state of immunologic balance that provides immune protection by decreasing risk of immunopathogenic injury to ocular tissues [45]. Anterior chamber associated immune deviation (ACAID) is an anti-inflammatory mechanism that is a form of eye-dependent tolerance mediated by ocular APCs. The immune deviation is initiated by F4/80+ ocular APCs that capture antigen in the eye and migrate via the blood to the spleen [46]. At that site, these APCs generate a population of regulatory T cells capable of inhibiting a Th1-mediated inflammatory immune responses such as a delayed type hypersensitivity response (DTH). We have previously demonstrated that D2 mice lack the ability to support ACAID as evidenced by their inability to inhibit a DTH response, but the genes responsible for this finding are not defined [20].
###end p 31
###begin p 32
###xml 250 252 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 253 255 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 360 366 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 447 453 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 695 701 686 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 782 784 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 815 821 806 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 921 923 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1005 1011 993 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1077 1082 1065 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1082 1083 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1086 1088 1074 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1082 1088 1070 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
Non-ocular APCs, such as F4/80+ macrophages derived from thioglycollate-elicited peritoneal exudate cells (PECs), can be converted into APCs that induce immune deviation similar to that induced by ocular APCs by exposing them to TGFbeta2 in culture [47-50]. Thus, TGFbeta-exposed peripheral APCs resemble ocular APCs in their functional phenotype. To test the Gpnmb dependency of this APC phenotype, we compared the ability of APCs with differing Gpnmb genotypes to induce immune deviation as detected by inhibition of DTH. To allow experiments with APCs in genetically identical hosts, all experiments used B6D2F1 mice as recipients. TGFbeta2-treated APCs from control B6 mice with a wild-type Gpnmb allele successfully induced immune deviation that led to inhibition of DTH (Fig. 5A). In contrast, APCs from both Gpnmb deficient and sufficient D2 mice failed to induce immune deviation when treated with TGFbeta2 (Fig. 5A). Thus, the inability of D2 APCs to mediate immune deviation is not dependent on Gpnmb alone. This suggests that some property of D2 APCS other than the GpnmbR150X mutation is responsible for their inability to induce immune deviation.
###end p 32
###begin p 33
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tolerogenic capacities and expression profiles of <italic>Gpnmb </italic>deficient APCs</bold>
###xml 72 76 72 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 988 991 977 980 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B-C</bold>
###xml 1183 1188 1172 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
###xml 1484 1489 1470 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Thbs1</italic>
###xml 1618 1626 1601 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tnfrsf1b</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
Tolerogenic capacities and expression profiles of Gpnmb deficient APCs. (A) OVA-pulsed APCs isolated from mice of the indicated genotypes were injected into B6D2F1/J recipients. Their ability to induce immune deviation was then measured. Absence of ear swelling indicated functional immune deviation through the suppression of a DTH response to the OVA challenge. We then tested their ability to induce immune deviation as detected by inhibition of DTH i.e. suppression of ear swelling in response to OVA challenge. The experimental summary for each group follows: Untreated (APCs cultured in media, injected into mice, immunization, challenge), TGFbeta2-treated (APCs cultured in presence of TGFbeta2, injected into mice, immunization, challenge), Neg. Control (challenge only). Induction of immune deviation is detected as the suppression of ear swelling response in the TGFbeta2-treated groups as compared to the untreated group. Ear swelling responses are presented as mean +/- SEM. (B-C) Gene expression profiles of APCs from indicated genotypes. Real-time PCR was employed to determine the expression levels of the indicated genes and expression of each gene was normalized to Gapdh. To faciliate visualization of the overall pattern of gene expression changes across these genes, the expression changes in response to TGFbeta2-treatment are summarized with an arrow (indicating up or down regulation) or a dash (indicating no change). TSP, thrombospondin 1, official gene name Thbs1; TGFbeta2, transforming growth factor, beta 2; TNFR2, tumor necrosis factor receptor superfamily, member 1b, official gene name Tnfrsf1b; CD40, CD40 antigen; IL-6, interleukin 6.
###end p 33
###begin p 34
###xml 90 95 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 95 96 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 95 96 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 96 101 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 101 102 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 105 107 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 101 107 98 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 182 187 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 187 188 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 187 188 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 188 193 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 193 194 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 197 199 194 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 193 199 190 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 416 418 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 419 421 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 451 456 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 456 457 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 456 457 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 457 462 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 462 463 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 466 468 463 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 462 468 459 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 548 550 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 594 600 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 636 641 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 641 643 635 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 641 643 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 691 693 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 897 903 891 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 907 913 901 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 944 946 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1150 1152 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1158 1163 1152 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1163 1165 1157 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1171 1176 1165 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 1176 1177 1170 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 1176 1177 1170 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 1177 1182 1171 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1182 1183 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1186 1188 1180 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1182 1188 1176 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 938 942 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
In parallel with these experiments, we tested the ability of TGFbeta-treated APCs from B6.Tyrp1bGpnmbR150X congenic mice to induce tolerance. These congenic mice have the D2-derived Tyrp1bGpnmbR150X mutations on a B6 genetic background (Methods). Also, we evaluated the expression of a panel of genes for which coordinate changes in expression normally contribute to the immune deviation inducing phenotype of APCs [51-53]. Similar to D2 APCs, the B6.Tyrp1bGpnmbR150X derived APCs failed to induce immune deviation when treated with TGFbeta2 (Fig. 5A). Arguing against a causative role for the Tyrp1 mutation, BALB/c mice have the same Tyrp1b mutation but do not have deficiencies in ACAID [20]. Together, our results suggest that a gene(s) that resides in one of the D2-derived chromosomal regions may be important in mediating APC induced tolerance. (D2-derived chromosomal regions surround the Tyrp1 and Gpnmb genes in the B6 congenic mice [43]). In agreement with this, the coordinated pattern of changes in gene expression that support immune deviating properties of APCs exhibited a classic tolerizing pattern in B6 mice, but not in D2 (Figure 5B), D2-Gpnmb+ or B6.Tyrp1bGpnmbR150X APCs (data not shown).
###end p 34
###begin title 35
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
Neither Gpnmb genotype, nor age, influence aqueous humor levels of IL18
###end title 35
###begin p 36
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 532 533 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 533 538 533 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 542 544 542 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 538 544 538 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 573 574 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 577 579 577 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 573 579 573 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 636 641 636 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 641 643 641 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 828 834 828 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1245 1251 1245 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
As an additional step toward defining the potential BM derived functions of Gpnmb, we next tested whether Gpnmb genotype influences IL18. Secretion of IL18 by macrophages has been implicated in both Th1 and Th2 immune responses. Aqueous humor levels of the immune modulating cytokine IL18 are reported to become elevated in D2 mice, and the levels of IL18 were suggested to associate with increases in IOP [21]. To test whether Gpnmb genotype influences IL18 levels, aqueous humor was collected from cohorts of either D2 or B6.Tyrp1bGpnmbR150X mice homozygous for the GpnmbR150X mutation and compared to the strain matched controls, D2-Gpnmb+ or C57BL/6J (Fig. 6A). Additionally, expression of IL18 mRNA in tissue enriched in ciliary body was analyzed by real-time PCR (Fig. 6B). In these mice, there was no correlation between Gpnmb genotype and IL18 levels. Furthermore, in contrast to previous studies of IL18 in D2 mice [21], we also found no correlation between IL18 and age. Indeed, in our studies, IL18 levels were significantly lower in 9 mo old D2 mice compared to 3 and 6 mo old D2 mice (P < 0.05). These results fail to support a role for IL18 in the D2 form of glaucoma and suggest that the relevant bone marrow derived functions of Gpnmb do not influence this aspect of ocular immunity.
###end p 36
###begin p 37
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL18 levels do not become elevated in D2 aqueous humor or ciliary body</bold>
###xml 72 76 72 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 149 154 149 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 286 290 286 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 425 430 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 430 432 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 444 445 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 454 456 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 450 456 450 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 519 525 519 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rn18s </italic>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
IL18 levels do not become elevated in D2 aqueous humor or ciliary body. (A) IL18 levels in aqueous humor of age matched D2, D2-Gpnmb+, B6.Tyrp1bGpnmbR150X, and C57BL/6J mice were determined by ELISA. IL18 levels are expressed as mean +/- SEM from 5 aqueous humor samples in each group. (B) Quantitative RT-PCR analysis comparing expression levels of IL18 transcript in ciliary body enriched dissections of 10.5 mo old D2, D2.Gpnmb+ and B6.Tyrp1bGpnmbR150X mice. The threshold cycle was calculated with normalization to Rn18s and values are expressed as mean +/- SEM, with 3-5 samples in each group.
###end p 37
###begin title 38
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
Deficiency of Rag1 does not affect Gpnmb mediated disease
###end title 38
###begin p 39
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 295 300 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 549 550 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 555 556 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 559 561 559 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 555 561 555 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 633 635 633 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 633 635 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 648 650 648 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 644 650 644 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 664 669 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 669 670 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 669 670 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 679 681 679 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 675 681 675 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 888 893 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 906 911 906 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 911 912 911 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 911 912 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 912 917 912 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 917 918 917 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 921 923 921 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 917 923 917 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 923 928 923 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mice </italic>
###xml 996 1001 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 1049 1050 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1112 1117 1112 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkdc</italic>
###xml 1117 1122 1117 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 1117 1122 1117 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>scid </italic></sup>
###xml 1194 1195 1194 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1380 1386 1380 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 1390 1396 1390 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1457 1463 1457 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 276 280 <span type="species:ncbi:10090">Mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
GPNMB is present within APCs and APCs initiate and direct adaptive immune responses. Therefore, we tested whether mature B or T lymphocytes, play a role in the Gpnmb mediated iris disease. To accomplish this, we exploited a mutation in the recombination activating gene Rag1. Mice deficient for Rag1 are characterized by arrested development of T and B cells and are therefore incapable of adaptive immune reactions mediated by mature T or B cells. To test the necessity of T and B cells for the pigment dispersing iris disease, we utilized B6.Tyrp1bGpnmbR150X mice [43] with a Rag1 mutation. As a consequence of the D2-derived Tyrp1b and GpnmbR150X mutations, B6.Tyrp1bGpnmbR150X mice develop an iris disease with near identical features to that of D2 mice [43]. Ablating the adaptive immune functions of T and B cell had no effect on the iris disease of these mice. The iris disease of Rag1 deficient B6.Tyrp1bGpnmbR150X mice is indistinguishable to that of their littermates with a functional Rag1 gene and an intact adaptive immune system (Fig. 7). Similar results were obtained with mice homozygous for the Prkdcscid mutation that also lack mature B and T lymphocytes [see Additional File 1]. These experiments demonstrate that the loss of adaptive immune reactions has no influence on the age of onset, rate of progression, or final severity of the iris disease mediated by Tyrp1 and Gpnmb mutations. Given the dependence of disease phenotypes on the Gpnmb genotype of bone marrow but not on adaptive immunity, these results suggest that GPNMB may impact innate immune processes. Therefore, alterations of innate immunity may participate in the pathogenesis of the iris disease.
###end p 39
###begin p 40
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Loss of adaptive immune reactions has no influence on <italic>Gpnmb </italic>mediated iris disease</bold>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 91 93 91 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mom </italic>
###xml 91 98 91 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm</italic>1<italic>Mom </italic></sup>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 277 279 277 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 273 279 273 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 487 493 487 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 516 520 516 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 609 613 609 613 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 639 645 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 774 778 774 778 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 839 844 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
Loss of adaptive immune reactions has no influence on Gpnmb mediated iris disease. The Rag1tm1Mom mutation acts recessively to result in a loss of adaptive immune responses due to lack of mature B and T lymphocytes. Stocks carrying this mutation were bred to B6.Tyrp1bGpnmbR150X mice. Triple mutant mice were isolated and aged, with typical eyes of indicated genotypes shown. The analysis strikingly demonstrates that the immune deficiency associated with Rag1 mutation has no effect on Gpnmb mediated iris disease. (A) Eyes of young B6 mice with wild-type Tyrp1, Gpnmb, and Rag1 alleles have healthy irides. (B) At 15 mo, mice mutant for Tyrp1 and Gpnmb exhibit iris disease characterized by significant pigment dispersion and iris atrophy. n = 10 eyes, age range 14-16 mo.(C) At 15 mo, immune deficient mice mutant for Tyrp1, Gpnmb, and Rag1 exhibit an iris disease indistinguishable from immune competent mice on the same genetic background. N = 26 eyes.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 689 695 689 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
D2 mice develop a pigmentary form of glaucoma involving a pigment dispersing iris disease, increased IOP, and degeneration of retinal ganglion cells [22-24,26]. In recent years, we have begun to study early events within the anterior chamber that initiate the iris disease and IOP elevation [20,22,23,43] as well as later events associated with the neurodegeneration [37,54,55]. We have previously identified two genes responsible for the initiation of this disease, Tyrp1 and Gpnmb, both of which encode melanosomal proteins [22,42,56]. We have also shown that a non-melanosomal component contributes to the D2 iris disease which acts via a BMC lineage [20]. Here, we have identified the Gpnmb gene as an important gene influencing these bone marrow derived contributions.
###end p 42
###begin p 43
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 793 798 793 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 798 800 798 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 896 902 896 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1084 1089 1084 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1089 1090 1089 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1093 1095 1093 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1089 1095 1089 1095 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 1209 1215 1209 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1262 1268 1262 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1427 1433 1427 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
###xml 1189 1193 <span type="species:ncbi:10090">mice</span>
From the sum of prior and present experiments (see Additional File 2 and refs [20,22]), an attractive hypothesis suggests that the D2 iris disease initially involves a melanosomal defect mediated by the Tyrp1 and Gpnmb genes that mildly damages the iris and causes cellular debris, including pigment, to be shed into the anterior chamber. Due to deficiency of GPNMB, a bone marrow derived lineage(s) that would normally express Gpnmb then reacts abnormally to the iris debris. This results in an inflammatory attack on the iris, severe iris atrophy and the ensuing glaucoma. The abnormally responding bone marrow derived lineage may either fail to inhibit ocular inflammation or may actively promote an inflammatory attack on the iris. This model accounts for the ability of B6D2F1 [20] or D2-Gpnmb+ (Fig. 2) bone marrow to suppress the D2 iris disease (because bone derived cells with wild-type Gpnmb alleles do not respond abnormally to the debris resulting from the melanosomal insults and mild iris damage). Additionally, this model explains why bone marrow from D2 mice with the GpnmbR150X mutation is not sufficient to confer the severe iris disease when transplanted into recipient mice with wild-type Gpnmb alleles (because the recipients with wild-type Gpnmb alleles do not have sufficient iris damage to prime the immune system attack of the iris.). Thus, this model, explains why the bone marrow derived function of Gpnmb is a necessary, but not sufficient, component of the overall disease.
###end p 43
###begin p 44
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 704 710 701 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1087 1089 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1158 1163 1155 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1163 1164 1160 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1167 1169 1164 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1163 1169 1160 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 1305 1309 <span type="species:ncbi:10090">mice</span>
The functions of Gpnmb in BMC derived lineage(s) that are relevant to DBA/2J glaucoma remain unknown. Although Gpnmb genotype did not influence the ability of D2 APCs to mediate tolerance to OVA when they were first exposed to TGFbeta2 and OVA in culture, GPNMB may still modulate some aspects of APCs that contribute to D2 phenotype and were not assessed. These functions may include their ability to process and present antigens derived from damaged iris cells, their ability to secrete various chemokines that recruit proinflammatory cells or their ability to respond to anti-inflammatory molecules in the ocular microenvironment. Regardless, we show that the immune abnormalities contributing to the Gpnmb mediated iris disease do not require functions of the adaptive immune system. This suggests that GPNMB deficiency may influence innate immune cells that are of bone marrow origin and are likely to respond to abnormalities in the iris. Experimental expression of GPNMB in activated macrophage causes reduced release of proinflammatory cytokines such as IL6, IL12 and TNF alpha [32]. We localize GPNMB within APCs. Therefore, it is possible that the GpnmbR150X mutation alters APCs so that they are more prone to mediate inflammation and this abnormal phenotype promotes ocular inflammation in D2 mice.
###end p 44
###begin p 45
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
Other groups have previously localized GPNMB in macrophages and in the MHC class II compartment of DCs [31]. The punctate localization of GPNMB in pigmented cells and its melanosomal targeting sequence are consistent with another function of GPNMB in melanosomes [22]. Interestingly, melanosomes and the MHC class II compartment are both lysosome-related organelles [57,58]. This correlation suggests that similar to molecules such as BLOC complexes and LYST [59,60], GPNMB may be a molecule that functions in multiple classes of lysosome-related organelles.
###end p 45
###begin p 46
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 199 201 199 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 195 201 195 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 210 212 210 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 210 212 210 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 703 709 703 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 713 718 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 1002 1008 1002 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1011 1017 1011 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
The glaucomatous potential of the DBA/2J iris disease has recently been shown to be strikingly sensitive to genetic background [43]. When transferred to the C57BL/6J genetic background, the GpnmbR150X and Tyrp1b mutations result in a severe pigment dispersing iris disease that is phenotypically indistinguishable from the iris disease of D2 mice. Surprisingly, however, these B6 mice are resistant to IOP elevation and glaucoma. Thus, there are additional modifier genes whose alleles determine whether or not IOP becomes elevated and glaucoma ensues. Although these modifier genes remain to be identified, our preliminary data suggest existence of at least 3 genetic loci, on different chromosomes to Gpnmb and Tyrp1, that impact the nature of the anterior chamber disease and determine if IOP becomes elevated. Given the dependence of the iris disease on bone marrow genotype, at least some of these modifiers are likely to influence immune functions. Since the chromosomal region containing either Gpnmb or Tyrp1 transferred the inability of APCs to mediate tolerance to the B6 congenic strain, there must be another strain specific allele that influences APC functions. Efforts to identify these strain specific modifier alleles are underway and are likely to shed additional light on the molecular basis of immune contributions to this glaucoma. Characterizing these genes is expected to improve understanding of APC responses within the anterior chamber and mechanisms of inducing tolerance.
###end p 46
###begin title 47
Conclusion
###end title 47
###begin p 48
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 331 338 <span type="species:ncbi:9606">patient</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
We have demonstrated that Gpnmb influences the glaucoma phenotype of D2 mice by a BM derived mechanism that does not require adaptive immunity. Although immunity has not yet been shown to contribute to human pigmentary glaucoma, the inflammation is subclinical in the mice and may have been undetectable on standard examination of patient's eyes. Thus, similar mechanisms of mild inflammation may be active in human pigmentary glaucoma and perhaps other ocular diseases in which pigment dispersal occurs within the anterior chamber. These findings represent an important step toward gaining a molecular understanding of the mechanisms active in this pigmentary form of glaucoma
###end p 48
###begin title 49
Methods
###end title 49
###begin title 50
Animal husbandry
###end title 50
###begin p 51
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 114 119 114 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 158 163 158 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 275 277 275 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 290 292 290 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 286 292 286 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 430 432 430 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm</italic>
###xml 433 436 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mom</italic>
###xml 430 436 430 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm</italic>1<italic>Mom</italic></sup>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 507 509 507 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 507 509 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b </italic></sup>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 518 520 518 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 514 520 514 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 602 604 602 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm</italic>
###xml 605 608 605 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mom</italic>
###xml 602 608 602 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm</italic>1<italic>Mom</italic></sup>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 613 614 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 613 614 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 619 620 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 623 624 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 619 624 619 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 659 664 659 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 664 665 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 664 665 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 670 671 670 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 670 675 670 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 721 727 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 791 797 791 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 812 817 812 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 817 818 817 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 841 846 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 846 847 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 923 928 923 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 928 929 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 932 934 932 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 928 934 928 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 1002 1007 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1007 1009 1007 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1053 1059 1053 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 1063 1069 1063 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1193 1203 1193 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">Mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
###xml 1340 1344 <span type="species:ncbi:10090">Mice</span>
D2 mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. Some studies also utilized B6.D2-Tyrp1bGpnmbR150X/Sj mice (referred to as B6 Tyrp1bGpnmbR150X), an N10 congenic strain of mice which are homozygous for chromosomal intervals containing the D2-derived Tyrp1b and GpnmbR150X mutations that have been backcrossed into the C57BL/6J genetic background [43]. Mice with a recombination activating gene 1 mutation (Rag1tm1Mom) were obtained from The Jackson Laboratory and crossed to the B6.Tyrp1b GpnmbR150X strain to produce mutants that were homozygous for all three mutations (B6.Cg-Rag1tm1MomTyrp1bGpnmbR150X/Sj, referred to as Rag1 mutant B6 Tyrp1bGpnmbR150X). Two strains of control mice with wild-type Gpnmb alleles were utilized in these studies, DBA/2J with a wild-type Gpnmb allele (DBA/2J-Gpnmb+/Sj, referred to as D2-Gpnmb+) [34] and C57BL/6J. Since the Gpnmb+allele is the ancestral D2 allele, the GpnmbR150X mutation is the only known genetic difference between the D2 and D2-Gpnmb+ strains [22]. C57BL/6J mice (with wild-type Tyrp1 and Gpnmb alleles) were obtained from The Jackson Laboratory. All D2 background mice were maintained on a 6% fat NIH 31 diet provided ad libitum, and the water was acidified to pH 2.8-3.2. All B6 background mice were similarly maintained but on an NIH 31 diet with 4% fat content. Mice were housed in cages containing white pine bedding and covered with polyester filters. The environment was kept at 21degreesC with a 14-h light:10-h dark cycle. All animals were treated according to the guidelines of the Association for Research in Vision and Ophthalmology for use of animals in research. All experimental protocols were approved by the Animal Care and Use Committee of The Jackson Laboratory or The University of Iowa.
###end p 51
###begin title 52
Generation and analysis of bone marrow chimeras
###end title 52
###begin p 53
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">137</sup>
###xml 210 212 209 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Bone marrow chimeras were generated as follows: 4-8 wk old female D2 and D2-Gpnmb+ mice were lethally irradiated (1000 rad from a 137Cs source) and then received 200 mul intravenous injections containing 5 x 106 T cell depleted bone marrow cells from the indicated donor strains. Donor marrow was depleted of T lymphocytes with 10 mug/mL of purified monoclonal antibodies to CD4 (GK1.5; The Jackson Laboratory Flow Cytometry Service, Bar Harbor, Maine) and CD8a (53-6.72; The Jackson Laboratory Flow Cytometry Service). Eyes of chimeras were clinically assayed at 2-3 mo intervals.
###end p 53
###begin title 54
Intraocular pressure measurement
###end title 54
###begin p 55
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
IOP was measured using the microneedle method as previously described in detail [61,62]. Because the IOPs of B6 mice are very consistent, B6 mice were interspersed with experimental mice during all experiments as a methodological control to ensure proper equipment calibration and performance.
###end p 55
###begin title 56
Slit-lamp examination
###end title 56
###begin p 57
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Eyes were examined with a slit-lamp bio-microscope and photographed with a 40x objective lens. Phenotypic assessment of iris disease was determined by indices of iris atrophy dispersed pigment and transillumination defects following previously described criteria [20,22-24]. Transillumination is an assay of iris disease whereby reflected light passing through depigmented areas of iris tissue are visualized as red light.
###end p 57
###begin title 58
RNA Isolation and Quantitative RT-PCR
###end title 58
###begin p 59
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
Tissues were dissected, homogenized, and total RNA extracted. cDNA was generated using 300 ng of total RNA isolated from dissected irides or 70 ng of total RNA isolated from ciliary body enriched dissections. Real-time PCR data were collected utilizing standard reaction conditions, with primer efficiencies determined from serial dilutions of cDNA and relative expression calculated as previously published [63-65]. Reaction conditions and primer sequences are available upon request.
###end p 59
###begin title 60
Western blotting
###end title 60
###begin p 61
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Iris tissue from D2 and D2-Gpnmb+ was homogenized in lysis buffer (10 mM Tris pH 7.6, 150 mM NACl, 1% Triton X-100 and supplemented with protease inhibitors). The lysate was resolved on a 4-20% SDS-PAGE gradient gel. Proteins were blotted to a PVDF membrane, followed by incubation with anti-GPNMB antibody (R&D systems), secondary antibody and detected using SuperSignal West Pico chemiluminescent substrate (Pierce Biotechnology).
###end p 61
###begin title 62
Immunohistochemistry
###end title 62
###begin p 63
###xml 511 517 <span type="species:ncbi:9793">donkey</span>
###xml 627 633 <span type="species:ncbi:9986">rabbit</span>
###xml 1016 1022 <span type="species:ncbi:9793">donkey</span>
###xml 1483 1489 <span type="species:ncbi:9986">rabbit</span>
Enucleated eyes were embedded in Optimal Cutting Temperature embedding medium (Tissue-Tek O.C.T. Compound, Sakura Finetek U.S.A., Inc., Torrance, CA), seven-micrometer sections cut, and sections transferred to glass slides (CryoJane, Instrumedics, Inc., St. Louis, MO). Cryosections were air dried for 30 min at room temperature, fixed for 5 min in ice-cold acetone, again air dried for 30 min at room temperature, and rehydrated in PBS for 5 min. Sections were blocked 1 hr at room temperature with 10% normal donkey serum and 30 mg/mL BSA in PBS. Primary antibodies were applied for 1 hr at room temperature using polyclonal rabbit anti-GPNMB antibody (diluted 1:200; R&D Systems Inc., Minneapolis, MN) or anti-F4/80 (diluted 1:200; Serotec Inc., Raleigh, NC). Primary antibody was removed by three washes (5 min each) in PBS and the sections were treated for 1 hr at room temperature with AlexaFluor conjugated secondary antibodies (1:200 dilution, Invitrogen-Molecular Probes, Carlsbad, CA) diluted in 1% normal donkey serum and 10 mg/mL BSA in PBS. After three washes in PBS, the sections were mounted (Vectashield, Vector Laboratories, Burlingame, CA) and viewed by fluorescence microscopy. All photomicrographs were taken with identical camera settings. For studies of bone marrow derived dendritic cell cultures, cells were fixed in 4% paraformaldehyde for 20 min at room temperature. Cells were permeabilized with PBS containing 0.1% Triton X-100, incubated with polyclonal rabbit anti-GPNMB antibody (diluted 1:200; R&D Systems Inc., Minneapolis, MN) for 1 hr at room temperature, washed three times in PBS, and treated for 1 hr at room temperature with FITC conjugated secondary antibodies (1:200 dilution, Jackson Immunoresearch, West Grove, PA). After three washes in PBS, the cells were mounted in fluorescent mounting medium (Vectashield, Vector Laboratories, Burlingame, CA) and viewed by confocal microscopy.
###end p 63
###begin title 64
Bone marrow derived dendritic cell cultures
###end title 64
###begin p 65
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
BM derived cells obtained from D2 or D2-Gpnmb+ mouse femur were cultured in the presence of GM-CSF (20 ng/ml) in 24 well plates (Costar Corp., Cambridge, MA). The nonadherent cells were removed from the culture and replated with fresh medium containing GM-CSF every alternate day. On day 10, cells were harvested and a subset analysed by flow cytometry. In the current experiments, >95% of cells labeled positive for the mouse APC marker CD11c.
###end p 65
###begin title 66
Analysis of aqueous humor IL18
###end title 66
###begin p 67
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
Aqueous humor was collected as described previously [21]. IL18 protein level in the aqueous humor was measured using a commercially available ELISA assay following the manufacturer's recommended protocol (Bender MedSystems, San Bruno, CA). Since overall protein levels in D2 aqueous humor are increased in older mice (at 6 and 9 mo) [20], samples were compared by analyzing equal volumes of aqueous humor rather than normalizing to total protein.
###end p 67
###begin title 68
Assay for immune deviation
###end title 68
###begin p 69
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 626 628 623 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 634 639 <span type="species:ncbi:10090">mouse</span>
###xml 740 743 <span type="species:ncbi:31658">CFA</span>
Peritoneal exudate cells (PECs) were obtained 3 days following 2 ml intra-peritoneal injections of a 3% thioglycollate solution (Sigma-Aldrich, St. Louis, MO). Plastic adherent macrophages from these cells were used as APCs (>95% F4/80+). Cells were cultured overnight (1 x 105/well) in a 96-well plate in the presence of TGFbeta2 (R&D Systems, CA, USA, 5 ng/ml final concentration) in serum free culture media, and pulsed with ovalbumin antigen (OVA) (7 mg/ml). Adherent cells were harvested, after washing off culture medium with cold Hank's balanced salt solution, and intravenously injected into B6D2F1 recipients (5 x 10 3 cells/mouse). Seven days following, recipients were immunized subcutaneously into the nape of the neck with OVA/CFA (50 mug). Animals that did not receive any APCs or immunization served as a negative control. A week later, animals in all groups received intra-dermal inoculation of OVA (200 mug/20 mul) into their right ear pinna. The left ear served as an untreated control. Thickness of both ears was measured immediately before and at 24-h interval after the OVA injection using a micrometer (Mitutoyo 227-101, MTI Corp., Paramus, NJ, USA). The measurements were performed in triplicates. Delayed type hypersensitivity (DTH) was measured as ear swelling [(24-h measurement - 0-h measurement in the experimental ear) - (24-h measurement - 0-h measurement in the untreated control ear)]. Immune deviation was detected as the suppression in DTH in the recipients of TGFbeta2 treated APCs as compared to those infused with untreated APCs. A two-tailed Student's t-test was used with significance assumed at P < 0.05. DTH results were confirmed by repeating the experiments a second time.
###end p 69
###begin title 70
Serum free medium
###end title 70
###begin p 71
###xml 349 350 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 373 374 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 375 376 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Serum-free medium (SFM) was used for in vitro assays. The medium contained: RPMI-1640, 10 mM HEPES, 0.1 mM NEAA, 1 mM Sodium pyruvate, 100 U/ml Penicillin, 100 mg/ml Streptomycin (Bio Whittaker, Walksville, MD), 0.1% BSA (Sigma-Aldrich, St. Louis, MO) and ITS+ culture supplement [1 mug/ml iron-free transferrin, 10 ng/ml linoleic acid, 0.3 ng/ml Na2Se and 0.2 mug/ml Fe(NO3)3] (Collaborative Biomedical Products, Bedford, MA).
###end p 71
###begin title 72
Genetic nomenclature and stocks
###end title 72
###begin p 73
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ipd </italic>
###xml 192 198 192 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 261 263 261 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 257 263 257 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 314 316 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b </italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">isa </italic>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 640 647 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm1Mom </italic>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 690 694 690 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 694 696 694 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm</italic>
###xml 697 701 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mom </italic>
###xml 694 701 694 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm</italic>1<italic>Mom </italic></sup>
###xml 734 738 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 738 740 738 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm</italic>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mom</italic>
###xml 738 744 738 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm</italic>1<italic>Mom</italic></sup>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkdc</italic>
###xml 860 865 860 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 987 992 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkdc</italic>
###xml 992 997 992 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 992 997 992 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>scid </italic></sup>
###xml 1029 1034 1029 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkdc</italic>
###xml 1034 1038 1034 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid</italic>
###xml 1034 1038 1034 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>scid</italic></sup>
###xml 464 469 <span type="species:ncbi:10090">mouse</span>
The official full names of genes (with abbreviations in parentheses), alleles, and stocks utilized in this study are as follows. 1. Glycoprotein (transmembrane) nmb (Gpnmb). The ipd allele of Gpnmb results from the R150X premature stop codon mutation, GpnmbR150X [22]. 2. Tyrosinase-related protein 1 (Tyrp1). The b allele of Tyrp1 encodes two amino acid substitutions compared to the C57BL/6J-derived allele [56]. This D2 allele is also referred to as isa in the mouse genome database and elsewhere [22,23]. The DBA/2J stock utilized here was stock number 000671 from The Jackson Laboratory. 3. Recombination activating gene 1 (Rag1). The tm1Mom mutation is a targeted knock-out [66]. The Rag1tm1Mom stock utilized here was B6.129S7-Rag1tm1Mom/J (stock 002216 from The Jackson Laboratory). 4. Protein kinase, DNA activated, catalytic polypeptide (Prkdc). The scid mutation arose spontaneously in the CB17 strain and has since been backcrossed onto C57BL/6J genetic background [67]. The Prkdcscid stock utilized here was B6.CB17-Prkdcscid/SzJ (stock 001913 from The Jackson Laboratory).
###end p 73
###begin title 74
Authors' contributions
###end title 74
###begin p 75
###xml 175 179 <span type="species:ncbi:10090">mice</span>
MGA, KSN, SM and SWMJ conceived experiments, analysed the data and prepared the manuscript. SWMJ oversaw all aspects of the study. MGA bred and performed clinical analysis of mice. KSN performed Western, ELISA and bone marrow derived dendritic cell culture experiments. LAA and CT performed tissue sectioning and immunohistochemistry. AM performed quantitative PCR. SM performed the ACAID and quantitative PCR experiments using PECs.
###end p 75
###begin title 76
Supplementary Material
###end title 76
###begin title 77
Additional file 1
###end title 77
###begin p 78
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 0 154 0 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Loss of adaptive immune reactions has no influence on the age of onset, rate of progression, or final severity of the <italic>Tyrp1 </italic>or <italic>Gpnmb </italic>mediated iris disease</bold>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 164 166 164 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tm</italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mom </italic>
###xml 164 171 164 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>tm</italic>1<italic>Mom </italic></sup>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkdc</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scid </italic>
###xml 180 185 180 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>scid </italic></sup>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b</italic></sup>
###xml 427 432 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 436 438 436 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 432 438 432 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 734 740 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkdc </italic>
###xml 766 772 766 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 775 781 775 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 869 875 869 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 879 884 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1 </italic>
###xml 930 936 930 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prkdc </italic>
###xml 1056 1062 1056 1062 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A to D</bold>
###xml 1148 1154 1148 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 1158 1164 1158 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1260 1266 1260 1266 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E to H</bold>
###xml 1290 1296 1290 1296 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I to L</bold>
###xml 1327 1333 1327 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 1337 1343 1337 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1430 1436 1430 1436 <bold xmlns:xlink="http://www.w3.org/1999/xlink">M to P</bold>
###xml 1459 1465 1459 1465 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Q to T</bold>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
###xml 1171 1175 <span type="species:ncbi:10090">mice</span>
###xml 1249 1253 <span type="species:ncbi:10090">mice</span>
###xml 1350 1354 <span type="species:ncbi:10090">mice</span>
###xml 1419 1423 <span type="species:ncbi:10090">mice</span>
Loss of adaptive immune reactions has no influence on the age of onset, rate of progression, or final severity of the Tyrp1 or Gpnmb mediated iris disease. The Rag1tm1Mom and Prkdcscid mutations both act recessively and result in essentially identical phenotypes characterized by loss of adaptive immune responses due loss of mature B and T lymphocytes. Stocks carrying each of these mutations were separately bred to B6.Tyrp1bGpnmbR150X mice. During the course of establishing triple mutant stocks, single and double mutant progeny classes were also isolated. Subsets of these were aged, with typical eyes of indicated genotypes shown. The combined analysis strikingly demonstrates that the immune deficiency associated with Rag1 or Prkdc mutation has no effect on Tyrp1 or Gpnmb mediated iris disease. Each column corresponds to a particular genotype with respect to Tyrp1 and Gpnmb; the rows are organized according to Rag1 or Prkdc genotype and age (homozygous mutants labeled as "Immune Deficient"; heterozygous and wild-type mice labeled "Normal"). (A to D) Eyes of young mice of all genotypes are characterized by healthy irides. By 8-9 mo, Tyrp1 and Gpnmb mutant mice exhibited typical signs of early disease that did not differ whether the mice were (E to H) immune competent, or (I to L) immune deficient. At 14+ mo, Tyrp1 and Gpnmb mutant mice exhibited signs of late disease that did not differ whether the mice were (M to P) immune competent or (Q to T) immune deficient. Panels K and Q are based on observations of 2 eyes, panel I from 6 eyes, and all other panels from groups of 8 to 26 eyes.
###end p 78
###begin p 79
Click here for file
###end p 79
###begin title 80
Additional file 2
###end title 80
###begin p 81
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 5 6 5 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 9 11 9 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 5 11 5 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Gpnmb</italic><sup><italic>R</italic>150<italic>X </italic></sup>mutation does not directly elevate IOP</bold>
###xml 150 151 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 174 179 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 179 180 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 183 185 181 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 179 185 177 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 444 446 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 447 449 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 538 543 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 543 544 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 547 549 545 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 543 549 541 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 668 674 666 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 811 817 809 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 818 823 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 823 824 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 823 825 821 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic>6</sup>
###xml 891 893 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 927 933 925 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 934 939 932 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 939 940 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 939 942 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic>2 </sup>
###xml 944 949 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 949 950 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 953 954 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 949 954 947 952 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X</italic></sup>
###xml 993 999 991 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1 </italic>
###xml 1003 1009 1001 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1059 1064 1057 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 1064 1065 1062 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1064 1066 1062 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic>6</sup>
###xml 1066 1071 1064 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1071 1072 1069 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1071 1074 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic>2 </sup>
###xml 1138 1144 1136 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb </italic>
###xml 1186 1191 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tyrp1</italic>
###xml 1191 1192 1189 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1191 1194 1189 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic>6 </sup>
###xml 1194 1199 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1199 1200 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1199 1202 1197 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic>2 </sup>
###xml 1247 1252 1245 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpnmb</italic>
###xml 1252 1253 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1256 1258 1254 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X </italic>
###xml 1252 1258 1250 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>R</italic>150<italic>X </italic></sup>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
GpnmbR150X mutation does not directly elevate IOP. Mean IOP +/- SEM is presented. For ease of comparison, some of the data are duplicated from Figure 3. It is clear that the GpnmbR150X mutation contributes to the iris disease of DBA/2J mice and is a critical component of the glaucoma. Manipulations that prevent severe iris disease in DBA/2J mice prevent both anterior chamber enlargement (a marker of IOP elevation) and glaucoma development [20,22]. Thus, the iris disease is an essential component of the glaucoma. To determine if the GpnmbR150X mutation also influences IOP independently of the iris disease, we have assessed IOP in aged DBA/2J mice that have the Gpnmb mutation in all tissues but that do not develop the severe iris disease. These mice were homozygous for the wild-type C57BL/6J allele of Tyrp1 (Tyrp1B6, that was backcrossed into DBA/2J for more than 10 generations) [34] and the mutant DBA/2J allele of Gpnmb (GpnmbD2 = GpnmbR150X). Since mutant DBA/2J alleles of both Tyrp1 and Gpnmb are necessary to develop severe iris disease, the Tyrp1B6GpnmbD2 mice did not do so. Importantly and despite the presence of the Gpnmb mutation in the iris and bone marrow, the Tyrp1B6 GpnmbD2 mice did not develop elevated IOP. Thus, the GpnmbR150X mutation does not induce high IOP directly but does so by inducing the iris disease.
###end p 81
###begin p 82
Click here for file
###end p 82
###begin title 83
Acknowledgements
###end title 83
###begin p 84
We thank O. Savinova and A. Bell for technical support in collection of IOP data as well as J. Torrance and F. Farley for help preparing the Figures and administrative assistance. We also wish to thank Dr. Wayne Streilein whose suggestions contributed to the initiation of these experiments. This work was supported in part by National Cancer Institute Grant CA34196 (to The Jackson Laboratory), and National Eye Institute Grants F32EY07015 (MGA) and EY11721 (SWMJ). SWMJ is an Investigator of The Howard Hughes Medical Institute.
###end p 84
###begin article-title 85
###xml 14 20 <span type="species:ncbi:9606">people</span>
The number of people with glaucoma worldwide in 2010 and 2020
###end article-title 85
###begin article-title 86
Glaucoma
###end article-title 86
###begin article-title 87
The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma
###end article-title 87
###begin article-title 88
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
###end article-title 88
###begin article-title 89
Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study
###end article-title 89
###begin article-title 90
Glaucoma: macrocosm to microcosm the Friedenwald lecture
###end article-title 90
###begin article-title 91
Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey
###end article-title 91
###begin article-title 92
A population-based evaluation of glaucoma screening: the Baltimore Eye Survey
###end article-title 92
###begin article-title 93
Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey
###end article-title 93
###begin article-title 94
Primary open-angle glaucoma
###end article-title 94
###begin article-title 95
Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study
###end article-title 95
###begin article-title 96
Ophthalmic drug discovery
###end article-title 96
###begin article-title 97
New paradigms in the mechanisms and management of glaucoma
###end article-title 97
###begin article-title 98
Current management of glaucoma
###end article-title 98
###begin article-title 99
Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye
###end article-title 99
###begin article-title 100
Mechanistic insights into glaucoma provided by experimental genetics the cogan lecture
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse genetics: a tool to help unlock the mechanisms of glaucoma
###end article-title 101
###begin article-title 102
The importance of models in glaucoma research
###end article-title 102
###begin article-title 103
By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma
###end article-title 103
###begin article-title 104
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma
###end article-title 104
###begin article-title 105
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice
###end article-title 105
###begin article-title 106
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice
###end article-title 106
###begin article-title 107
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice
###end article-title 107
###begin article-title 108
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma
###end article-title 108
###begin article-title 109
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration
###end article-title 109
###begin article-title 110
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice
###end article-title 110
###begin article-title 111
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice
###end article-title 111
###begin article-title 112
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma
###end article-title 112
###begin article-title 113
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric
###end article-title 113
###begin article-title 114
Molecular cloning of a dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparan sulfate proteoglycans
###end article-title 114
###begin article-title 115
Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses
###end article-title 115
###begin article-title 116
DC-HIL is a negative regulator of T lymphocyte activation
###end article-title 116
###begin article-title 117
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1
###end article-title 117
###begin article-title 118
IL-18 in autoimmunity: review
###end article-title 118
###begin article-title 119
Nonsense-mediated mRNA decay in mammals
###end article-title 119
###begin article-title 120
High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma
###end article-title 120
###begin article-title 121
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Identification and characterization of the genes encoding human and mouse osteoactivin
###end article-title 121
###begin article-title 122
Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts
###end article-title 122
###begin article-title 123
Characterization of a new melanocyte-specific gene (QNR-71) expressed in v-myc-transformed quail neuroretina
###end article-title 123
###begin article-title 124
###xml 23 29 <span type="species:ncbi:10090">murine</span>
mRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris
###end article-title 124
###begin article-title 125
The AP-3-dependent targeting of the melanosomal glycoprotein QNR-71 requires a di-leucine-based sorting signal
###end article-title 125
###begin article-title 126
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma
###end article-title 126
###begin article-title 127
###xml 119 122 <span type="species:ncbi:10116">rat</span>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye
###end article-title 127
###begin article-title 128
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
###end article-title 128
###begin article-title 129
Immunoregulatory properties of bone marrow-derived cells in the iris and ciliary body
###end article-title 129
###begin article-title 130
Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye
###end article-title 130
###begin article-title 131
Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type
###end article-title 131
###begin article-title 132
Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta
###end article-title 132
###begin article-title 133
Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta
###end article-title 133
###begin article-title 134
TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells
###end article-title 134
###begin article-title 135
###xml 72 78 <span type="species:ncbi:10090">murine</span>
Requirement for early donor cell chimerism during prolonged survival of murine skin allografts
###end article-title 135
###begin article-title 136
Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells
###end article-title 136
###begin article-title 137
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice
###end article-title 137
###begin article-title 138
Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage
###end article-title 138
###begin article-title 139
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
The molecular basis of brown, an old mouse mutation, and of an induced revertant to wild type
###end article-title 139
###begin article-title 140
Lysosome-related organelles
###end article-title 140
###begin article-title 141
Lysosome-related organelles: a view from immunity and pigmentation
###end article-title 141
###begin article-title 142
Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles
###end article-title 142
###begin article-title 143
Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function
###end article-title 143
###begin article-title 144
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Intraocular pressure in inbred mouse strains
###end article-title 144
###begin article-title 145
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Intraocular pressure in genetically distinct mice: an update and strain survey
###end article-title 145
###begin article-title 146
Evaluation of real-time PCR amplification efficiencies to detect PCR inhibitors
###end article-title 146
###begin article-title 147
A new mathematical model for relative quantification in real-time RT-PCR
###end article-title 147
###begin article-title 148
Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data
###end article-title 148
###begin article-title 149
###xml 16 20 <span type="species:ncbi:10090">mice</span>
RAG-1-deficient mice have no mature B and T lymphocytes
###end article-title 149
###begin article-title 150
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse
###end article-title 150

